NDC 80425-0004-01 - Cephalexin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0004
- Requested NDC
- 80425-0004-01
- Package NDCs from labels
- 80425-0004-1, 80425-0004-2, 80425-0004-3, 80425-0004-4, 80425-0004-5, 80425-0004-6, 80425-0004-7, 80425-0004-01
- Manufacturer
- ADVANCED RX PHARMACY OF TENNESSEE, LLC
- Effective date
- 2024-03-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cephalexin - ADVANCED RX PHARMACY OF TENNESSEE, LLC | ADVANCED RX PHARMACY OF TENNESSEE, LLC | 2024-03-12 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0004-1 | Cephalexin | 28 in 1 BOTTLE | CAPSULE | 28 | 5 | |
| 80425-0004-2 | Cephalexin | 40 in 1 BOTTLE | CAPSULE | 40 | 5 | |
| 80425-0004-3 | Cephalexin | 6 in 1 BOTTLE | CAPSULE | 6 | 5 | |
| 80425-0004-4 | Cephalexin | 5 in 1 BOTTLE | CAPSULE | 5 | 5 | |
| 80425-0004-5 | Cephalexin | 14 in 1 BOTTLE | CAPSULE | 14 | 5 | |
| 80425-0004-6 | Cephalexin | 20 in 1 BOTTLE | CAPSULE | 20 | 5 | |
| 80425-0004-7 | Cephalexin | 30 in 1 BOTTLE | CAPSULE | 30 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0004 | CEPHALEXIN CAPSULE [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 5 | Current NDC, Legacy NDC, 7 package rows | 20240314_af49507d-254f-296d-e053-2a95a90ad263.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0004-1 | EA - Each | 80425-0004 | 568b0d95-e053-4078-9588-aae633aac1c8 | 1 | 2023-03-13 |
| 80425-0004-2 | EA - Each | 80425-0004 | 08cd35d1-2cad-40a7-91fb-fdb8337d9e65 | 1 | 2023-03-13 |
| 80425-0004-3 | EA - Each | 80425-0004 | fbaf8b0f-38f5-4531-9f5b-26ccf9d8e766 | 1 | 2024-06-10 |
| 80425-0004-4 | EA - Each | 80425-0004 | 49b4d903-13ce-40d3-89cf-31cd97d711e7 | 1 | 2024-04-05 |
| 80425-0004-5 | EA - Each | 80425-0004 | 1020912e-44d0-4ba7-bbbc-b3ce215a7748 | 1 | 2024-04-05 |
| 80425-0004-6 | EA - Each | 80425-0004 | 88fa8483-8c3b-4c86-bbfe-68a6da75564f | 1 | 2024-04-05 |
| 80425-0004-7 | EA - Each | 80425-0004 | 9246bd25-019c-471d-a5b0-e435a401b8e4 | 1 | 2024-04-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| cephalexin | CEPHALEXIN | A-S Medication Solutions | 0a24b6e5-6f13-44b4-93f4-47c86945cad2 | 2023-04-26 | Warnings, Adverse reactions | OBN7UDS42Y |
| CEPHALEXIN | CEPHALEXIN | DIRECT RX | 2d12e6a9-f7dd-25ed-e054-00144ff8d46c | 2022-09-29 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Asclemed USA, Inc. | 6032b68f-16d8-41b6-bd2c-86d5406a757a | 2022-09-21 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Asclemed USA, Inc. | 891b8c0e-dbf4-4b0e-ba3f-c4c49d51510d | 2022-07-20 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Ascend Laboratories, LLC | bb28751c-bd1b-4e7f-8271-a14c1b4314e3 | 2022-07-07 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Proficient Rx LP | febab51b-6b48-488a-8fd1-d24400e5df1d | 2022-07-01 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Proficient Rx LP | dec3a1ef-1e85-4236-804b-e7a343d3a58f | 2022-05-02 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Proficient Rx LP | ada7b8a5-98f4-454c-b38f-92192d4db33f | 2021-08-01 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Pharma-C, Inc. | bf9a6c06-11fd-4fb7-9cf5-e8e787758c1c | 2016-12-09 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.